Anatomy, Biology and Concepts, Pertaining to Lung Cancer Stage Classification
MET Pathway as a Therapeutic Target
The Src Inhibitor AZD0530 Blocks Invasion and May Act as a Radiosensitizer in Lung Cancer Cells
INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma
Angiogenic Markers Show High Prognostic Impact on Survival in Marginally Operable Non-small Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
MYC and EIF3H Coamplification Significantly Improve Response and Survival of Non-small Cell Lung Cancer Patients (NSCLC) Treated with Gefitinib
Evaluation of Glutathione Metabolic Genes on Outcomes in Advanced Non-small Cell Lung Cancer Patients after Initial Treatment with Platinum-Based Chemotherapy
BCL-2 Expression is Prognostic for Improved Survival in Non-small Cell Lung Cancer
Survival and Treatment Pattern of Non-small Cell Lung Cancer Over 20 Years
Cost-Effectiveness of a Smoking Cessation Program Implemented at the Time of Surgery for Lung Cancer
Do Evolving Practices Improve Survival in Operated Lung Cancer Patients? A Biobank May Answer
First Line Chemotherapy with Weekly Docetaxel and Cisplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer
Comparative Chemotherapeutic Efficacy in Non-small Cell Lung Cancer Patients with Postoperative Recurrence and Stage IV Disease
Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer
A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596)
Extracapsular Lymph Node Involvement Is a Negative Prognostic Factor After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Cancer
Metastases to Breast from Primary Lung Cancer
Pulmonary Blastoma with Endobronchial Growth
Preinvasive Lesions of the Bronchus
Pulmonary Metastases from Cervical Adenocarcinoma Regress to a ‘Hole’ Lot of Nothing
Nasion Swelling as the Presenting Symptom of Lung Adenocarcinoma
ERRATUM
Absence of Mutations in the Epidermal Growth Factor Receptor (EGFR) Kinase Domain in Patients with Mesothelioma
Carboplatin and Weekly Paclitaxel for the Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) During Pregnancy
Meeting Announcements